View in EDS

Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.

Saved in:
Bibliographic Details
Title: Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.
Authors: Allegretti, Jessica R.1,2 (AUTHOR) jallegretti@bwh.harvard.edu, Cheifetz, Adam S.2,3 (AUTHOR) acheifet@bidmc.harvard.edu, Dulai, Parambir S.4 (AUTHOR) parambir.dulai@northwestern.edu, Stevens, A.C.5 (AUTHOR) aclstevens@gmail.com, Chapas-Reed, Jillian5 (AUTHOR) jchapasreed@adisotx.com, Chesnel, Laurent5 (AUTHOR) laurent_chesnel@hotmail.com, Dixit, Bharat5 (AUTHOR) bdixit@adisotx.com, Farquhar, Ronald5 (AUTHOR) rfarquhar981@gmail.com, Ghahramani, Parviz6 (AUTHOR) parviz.ghahramani@inncelerex.com, Miller, Benjamin W.5 (AUTHOR) bwmiller.4@gmail.com, Murphy, Christopher K.5 (AUTHOR) chriskmurphy@hotmail.com, Quintas, Megan5 (AUTHOR) Megan.Quintas@icloud.com, Tanase, Raisa7 (AUTHOR) raisa.tanase.ext@arensia-em.com, Telia, Tengiz8 (AUTHOR) tengiz.telia.ext@arensia-em.com, Woźniak-Stolarska, Barbara9 (AUTHOR) basiastolarska@interia.pl, Gupta, Renu5 (AUTHOR) renu.gupta@medstech.com
Source: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Jul2025, Vol. 120 Issue 7, p1624-1635. 12p.
Database: Academic Search Ultimate
Description
ISSN:00029270
DOI:10.14309/ajg.0000000000003269